The role of radiation therapy in the management of adrenal carcinoma and adrenal metastases

Journal of Surgical Oncology

Volumn 106, Issue 5, 2012, Pages 647-650

  Milgrom, Sarah A ^a   Goodman, Karyn A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

adrenal; radiation

Indexed keywords

CYTOTOXIC AGENT; MITOTANE;

ADRENAL CORTEX CARCINOMA; ADRENAL METASTASIS; ADRENALECTOMY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; DISEASE FREE SURVIVAL; HUMAN; INTENSITY MODULATED RADIATION THERAPY; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; RADIATION INJURY; RADIATION SAFETY; REVIEW; STEREOTACTIC RADIOSURGERY;

ADRENAL GLAND NEOPLASMS; ANIMALS; DISEASE MANAGEMENT; HUMANS;

EID: 84866428358     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23096     Document Type: Review

References (40)

1. Schteingart DE, Doherty GM, Gauger PG, et al.: Management of patients with adrenal cancer: Recommendations of an International Consensus Conference. Endocr Relat Cancer 2005; 12: 667-680. (Pubitemid 41483000)
2. Lacroix A,: Approach to the patient with adrenocortical carcinoma. J Clin Endocrinol Metab 2010; 95: 4812-4822.
3. Bellantone R, Ferrante A, Boscherini M, et al.: Role of reoperation in recurrence of adrenal cortical carcinoma: Results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery 1997; 122: 1212-1218. (Pubitemid 28016693)
4. Gonzalez RJ, Tamm EP, Ng C, et al.: Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma. Surgery 2007; 142: 867-875, discussion 867-875. (Pubitemid 350193248)
5. Icard P, Chapuis Y, Andreassian B, et al.: Adrenocortical carcinoma in surgically treated patients: A retrospective study on 156 cases by the French Association of Endocrine Surgery. Surgery 1992; 112: 972-979, discussion 979-980.
6. Fassnacht M, Hahner S, Polat B, et al.: Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. J Clin Endocrinol Metab 2006; 91: 4501-4504. (Pubitemid 44833430)
7. Bilimoria KY, Shen WT, Elaraj D, et al.: Adrenocortical carcinoma in the United States: Treatment utilization and prognostic factors. Cancer 2008; 113: 3130-3136.
8. Schulick RD, Brennan MF,: Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 1999; 6: 719-726. (Pubitemid 30013647)
9. Cohn K, Gottesman L, Brennan M,: Adrenocortical carcinoma. Surgery 1986; 100: 1170-1177. (Pubitemid 17223238)
10. Hutter AM, Jr., Kayhoe DE,: Adrenal cortical carcinoma. Clinical features of 138 patients. Am J Med 1966; 41: 572-580.
11. Bodie B, Novick AC, Pontes JE, et al.: The Cleveland Clinic experience with adrenal cortical carcinoma. J Urol 1989; 141: 257-260. (Pubitemid 19061293)
12. Kasperlik-Zaluska AA, Migdalska BM, Zgliczynski S, et al.: Adrenocortical carcinoma. A clinical study and treatment results of 52 patients. Cancer 1995; 75: 2587-2591.
13. Pommier RF, Brennan MF,: An eleven-year experience with adrenocortical carcinoma. Surgery 1992; 112: 963-970, discussion 970-961.
14. Sabolch A, Feng M, Griffith K, et al.: Adjuvant and definitive radiotherapy for adrenocortical carcinoma. Int J Radiat Oncol Biol Phys 2011; 80: 1477-1484.
15. Polat B, Fassnacht M, Pfreundner L, et al.: Radiotherapy in adrenocortical carcinoma. Cancer 2009; 115: 2816-2823.
16. Percarpio B, Knowlton AH,: Radiation therapy of adrenal cortical carcinoma. Acta Radiol Ther Phys Biol 1976; 15: 288-292.
17. King DR, Lack EE,: Adrenal cortical carcinoma: A clinical and pathologic study of 49 cases. Cancer 1979; 44: 239-244. (Pubitemid 9234938)
18. Markoe AM, Serber W, Micaily B, et al.: Radiation therapy for adjunctive treatment of adrenal cortical carcinoma. Am J Clin Oncol 1991; 14: 170-174.
19. Kebebew E, Reiff E, Duh QY, et al.: Extent of disease at presentation and outcome for adrenocortical carcinoma: Have we made progress? World J Surg 2006; 30: 872-878. (Pubitemid 43724119)
20. Paton BL, Novitsky YW, Zerey M, et al.: Outcomes of adrenal cortical carcinoma in the United States. Surgery 2006; 140: 914-920, discussion 919-920. (Pubitemid 44937380)
21. Cerquetti L, Sampaoli C, Amendola D, et al.: Mitotane sensitizes adrenocortical cancer cells to ionizing radiations by involvement of the cyclin B1/CDK complex in G2 arrest and mismatch repair enzymes modulation. Int J Oncol 2010; 37: 493-501.
22. Cerquetti L, Bucci B, Marchese R, et al.: Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines. Endocr Relat Cancer 2008; 15: 623-634. (Pubitemid 351880848)
23. Abrams HL, Spiro R, Goldstein N,: Metastases in carcinoma; Analysis of 1000 autopsied cases. Cancer 1950; 3: 74-85.
24. Gittens PR, Jr., Solish AF, Trabulsi EJ,: Surgical management of metastatic disease to the adrenal gland. Semin Oncol 2008; 35: 172-176. (Pubitemid 351469910)
25. Lumb G, Mackenzie DH,: The incidence of metastases in adrenal glands and ovaries removed for carcinoma of the breast. Cancer 1959; 12: 521-526.
26. Strong VE, D'Angelica M, Tang L, et al.: Laparoscopic adrenalectomy for isolated adrenal metastasis. Ann Surg Oncol 2007; 14: 3392-3400. (Pubitemid 350160106)
27. Sarela AI, Murphy I, Coit DG, et al.: Metastasis to the adrenal gland: The emerging role of laparoscopic surgery. Ann Surg Oncol 2003; 10: 1191-1196. (Pubitemid 40486815)
28. Kim SH, Brennan MF, Russo P, et al.: The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer 1998; 82: 389-394. (Pubitemid 28060257)
29. Higashiyama M, Doi O, Kodama K, et al.: Surgical treatment of adrenal metastasis following pulmonary resection for lung cancer: Comparison of adrenalectomy with palliative therapy. Int Surg 1994; 79: 124-129. (Pubitemid 24214004)
30. Duh QY,: Resecting isolated adrenal metastasis: Why and how? Ann Surg Oncol 2003; 10: 1138-1139.
31. Luketich JD, Burt ME,: Does resection of adrenal metastases from non-small cell lung cancer improve survival? Ann Thorac Surg 1996; 62: 1614-1616. (Pubitemid 26421089)
32. Tanvetyanon T, Robinson LA, Schell MJ, et al.: Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: A systematic review and pooled analysis. J Clin Oncol 2008; 26: 1142-1147.
33. Timmerman R, Bastasch M, Saha D, et al.: Stereotactic body radiation therapy: Normal tissue and tumor control effects with large dose per fraction. Front Radiat Ther Oncol 2011; 43: 382-394.
34. Casamassima F, Livi L, Masciullo S, et al.: Stereotactic radiotherapy for adrenal gland metastases: University of Florence experience. Int J Radiat Oncol Biol Phys 2012; 82: 919-923.
35. Oshiro Y, Takeda Y, Hirano S, et al.: Role of radiotherapy for local control of asymptomatic adrenal metastasis from lung cancer. Am J Clin Oncol 2011; 34: 249-253.
36. Holy R, Piroth M, Pinkawa M, et al.: Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer. Strahlenther Onkol 2011; 187: 245-251.
37. Barney BM, Olivier KR, Macdonald OK, et al.: Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors. Am J Clin Oncol 2011 [Epub ahead of print].
38. Chawla S, Chen Y, Katz AW, et al.: Stereotactic body radiotherapy for treatment of adrenal metastases. Int J Radiat Oncol Biol Phys 2009; 75: 71-75.
39. Katoh N, Onimaru R, Sakuhara Y, et al.: Real-time tumor-tracking radiotherapy for adrenal tumors. Radiother Oncol 2008; 87: 418-424.
40. Torok J, Wegner RE, Burton SA, et al.: Stereotactic body radiation therapy for adrenal metastases: A retrospective review of a noninvasive therapeutic strategy. Future Oncol 2011; 7: 145-151.